CS199694B2 - Process for preparing 5-/phenyl substituted/-oxazolidinone and sulphur derivatives thereof - Google Patents

Process for preparing 5-/phenyl substituted/-oxazolidinone and sulphur derivatives thereof Download PDF

Info

Publication number
CS199694B2
CS199694B2 CS778086A CS808677A CS199694B2 CS 199694 B2 CS199694 B2 CS 199694B2 CS 778086 A CS778086 A CS 778086A CS 808677 A CS808677 A CS 808677A CS 199694 B2 CS199694 B2 CS 199694B2
Authority
CS
Czechoslovakia
Prior art keywords
group
mmol
phenyl
dimethoxyphenyl
formula
Prior art date
Application number
CS778086A
Other languages
Czech (cs)
English (en)
Inventor
Andreas Huth
Ralph Schmiechen
Wolfgang Kehr
Gert Paschelke
Helmut Wachtel
Herbert H Schneider
Dieter Palenschat
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762655369 external-priority patent/DE2655369A1/de
Priority claimed from DE19772745320 external-priority patent/DE2745320A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS199694B2 publication Critical patent/CS199694B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS778086A 1976-12-03 1977-12-05 Process for preparing 5-/phenyl substituted/-oxazolidinone and sulphur derivatives thereof CS199694B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762655369 DE2655369A1 (de) 1976-12-03 1976-12-03 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
DE19772745320 DE2745320A1 (de) 1977-10-05 1977-10-05 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung ii

Publications (1)

Publication Number Publication Date
CS199694B2 true CS199694B2 (en) 1980-07-31

Family

ID=25771221

Family Applications (1)

Application Number Title Priority Date Filing Date
CS778086A CS199694B2 (en) 1976-12-03 1977-12-05 Process for preparing 5-/phenyl substituted/-oxazolidinone and sulphur derivatives thereof

Country Status (19)

Country Link
JP (1) JPS5382777A (fr)
AT (1) AT357529B (fr)
AU (1) AU519994B2 (fr)
CA (1) CA1097657A (fr)
CH (1) CH635578A5 (fr)
CS (1) CS199694B2 (fr)
DD (1) DD133667A5 (fr)
DK (1) DK149850C (fr)
FR (1) FR2372814A1 (fr)
GB (1) GB1588639A (fr)
GR (1) GR64964B (fr)
HU (1) HU175676B (fr)
IE (1) IE46435B1 (fr)
IL (1) IL53520A (fr)
IT (1) IT1089341B (fr)
LU (1) LU78616A1 (fr)
NL (1) NL7713153A (fr)
SE (1) SE441446B (fr)
SU (1) SU888821A3 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2701215C2 (de) * 1977-01-13 1982-10-14 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Thiazolin-2-thionen
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
DE3438839A1 (de) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische praeparate
WO1987006576A1 (fr) * 1986-04-29 1987-11-05 Pfizer Inc. ANTIDEPRESSEUR INHIBITEUR DE PHOSPHODIESTERASE DE MPA-c INDEPENDANTE DU CALCIUM
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
JPH01135098U (fr) * 1988-03-11 1989-09-14
WO1991007177A1 (fr) * 1989-11-13 1991-05-30 Pfizer Inc. Derives de pyrimidone et analogues pour le traitement de l'asthme et de certaines maladies de la peau
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
JP3806144B2 (ja) * 1993-12-22 2006-08-09 セルテック セラピューティックス リミテッド 三置換フェニル誘導体、その調製方法とホスホジエステラーゼ(iv型)阻害剤としてのその使用
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
EP0946523A1 (fr) 1996-12-23 1999-10-06 Celltech Therapeutics Limited Derives polycyclique fondus de 2-aminopyrimidine, leur preparation et leur utilisation comme inhibiteurs de proteine tyrosine-kinase
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
AT357529B (de) 1980-07-10
NL7713153A (nl) 1978-06-06
AU3117577A (en) 1979-06-07
JPS5382777A (en) 1978-07-21
IL53520A0 (en) 1978-03-10
IT1089341B (it) 1985-06-18
LU78616A1 (fr) 1978-04-20
SU888821A3 (ru) 1981-12-07
CH635578A5 (en) 1983-04-15
GB1588639A (en) 1981-04-29
IE46435B1 (en) 1983-06-15
JPS6154792B2 (fr) 1986-11-25
FR2372814A1 (fr) 1978-06-30
IE772446L (en) 1978-06-03
ATA868677A (de) 1979-12-15
CA1097657A (fr) 1981-03-17
FR2372814B1 (fr) 1980-10-10
AU519994B2 (en) 1982-01-07
SE441446B (sv) 1985-10-07
HU175676B (hu) 1980-09-28
IL53520A (en) 1981-07-31
SE7713635L (sv) 1978-06-04
DK536677A (da) 1978-06-04
DK149850B (da) 1986-10-13
DD133667A5 (de) 1979-01-17
GR64964B (en) 1980-06-10
DK149850C (da) 1987-04-27

Similar Documents

Publication Publication Date Title
CS199694B2 (en) Process for preparing 5-/phenyl substituted/-oxazolidinone and sulphur derivatives thereof
JP2656189B2 (ja) ベンゾイソチアゾールおよびベンゾイソキサゾール−3−カルボキサミド、その製法およびそれよりなる抗精神病剤
KR920000761B1 (ko) 치환된 2-피리미디닐-1-피페라진 유도체의 제조방법
EP0486666B1 (fr) Composes heterocycliques therapeutiques
AU624092B2 (en) 3-(4(1-substituted-4-piperazinyl)butyl)-4-thiazolidinones a process for their preparation and their use as medicaments
JP3638874B2 (ja) 新規なピペラジンおよびピペリジン化合物
NZ286720A (en) 4-phenylpiperazinopropyl pyrimidinedione derivatives and analogs and medicaments
DK149623B (da) Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider
DE68910451T2 (de) 1,4-benzoxazin- und 1,4-benzothiazin-derivate und verfahren zu deren herstellung.
US6407255B2 (en) Chemical synthesis of 1,2,4-triazolinone derivative
US4824833A (en) Benzoxazine derivatives
EP0401707B1 (fr) Composés de triazine ou triazolo hétérocycliques avec activité d'antagoniste de sérotonine 2-récepteur
CS225816B2 (en) The production process of the alkoxyphenylpyrrolidone with the cyclic substituents and with the nitrogen on the end of the aliphatic chain
CZ15997A3 (en) 3-substituted derivatives of 3h-2-3-benzodiazepine, process of their preparation, their use in medicaments and pharmaceutical composition containing thereof
DD273440A5 (de) Verfahren zur herstellung von 1,2 benzisoxazolen und 1,2-benziothiazolen
EP0003360B1 (fr) Azathianaphtalènes, procédé pour leur préparation, préparations pharmaceutiques les contenant et leur utilisation
JPH0342276B2 (fr)
WO1997005134A1 (fr) Composes heterocycliques pour le traitement de l'ischemie myocardique
JPH04210984A (ja) 環生成されたイミノチアゾールの製法及び中間体
JPS62292763A (ja) アルアルキルイミダゾ−ル誘導体
JPS6293272A (ja) ピペラジン誘導体及びその製法
CS227047B2 (cs) Způsob výroby derivátů karbazol-4-yloxypropanolaminu
MXPA00012725A (en) Chemical synthesis of morpholine derivatives
EP0137083A1 (fr) Dérivés de 1,5-benzothiazépine et leur procédé préparation
CS201042B2 (cs) Způsob výroby etherifikovaných hydroxybenzodiheterocyklických sloučenin